DISCOUNT ZERTIFIKAT - EDWARDS LIFESCIENCES | Market Closed - Deutsche Boerse AG 15:40:21 2024-06-14 EDT | ||
| 69.94 EUR | +0.37% |
|
| Current month | +1.60% | ||
| 1 month | +1.73% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-06-14 | 69.94 | +0.37% |
| 24-06-13 | 69.68 | +0.62% |
| 24-06-12 | 69.25 | -0.56% |
| 24-06-11 | 69.64 | +0.19% |
| 24-06-10 | 69.51 | +0.45% |
Delayed Quote Deutsche Boerse AG
Last update June 14, 2024 at 03:40 pm
More quotesStatic data
| Product type | Certificats Discount |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
BNP Paribas
|
| WKN | PZ0VGK |
| ISIN | DE000PZ0VGK3 |
| Date issued | 2023-10-31 |
| Cap | 75 $ |
| Last trading day | 2024-06-21 |
| Maturity | 2024-06-21 (6 Days) |
| Parity | 1 : 1 |
| Emission price | 59.4 € |
| Emission volume | N/A |
| Payment day | 2024-06-27 |
| Bonus | - € |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Discount (ask) | 0.000000 % |
|---|---|
| Sideways yield | 0.000000 % |
| Sideways yield pa | 0.000000 % |
| Outperformance point | - $ |
| Break even | 0.000000 € |
| Highest since issue | 70.13 € |
| Lowest since issue | 55.99 € |
| Distance Cap | 12.29 $ |
| Distance Cap % | +14.08% |
| Max. earning | - |
| Max. earning % | 0.000000 % |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
87.29
USD
Average target price
96.24
USD
Spread / Average Target
+10.25%
- Stock Market
- Certificates
- Certificat
